UNITED THERAPEUTICS Corp (UTHR) › Cost of RevenueUNITED THERAPEUTICS Corp (UTHR) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $72.70M2017: $105.70M2018: $198.70M2019: $117.60M2020: $108.10M2021: $122.50M2022: $151.60M2023: $257.50M2024: $309.70M2025: $384.40M$384.40M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$384.40M+24.1%2024$309.70M+20.3%2023$257.50M+69.9%2022$151.60M+23.8%2021$122.50M+13.3%2020$108.10M-8.1%2019$117.60M-40.8%2018$198.70M+88.0%2017$105.70M+45.4%2016$72.70M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share